NUSAP1 and oral cavity squamous cell carcinoma: Further, NUSAP1 could be a biomarker of oral squamous cell carcinoma, as it was reported that downregulation of NUSAP1 suppressed tumor proliferation and enhanced the anti-tumor effect of paclitaxel [44].